Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients.

According to the current European legislation, the safety assessment of each individual cosmetic ingredient of any formulation is the basis for the safety evaluation of a cosmetic product. Also, animal testing in the European Union is prohibited for cosmetic ingredients and products since 2004 and 2009, respectively. Additionally, the commercialization of any cosmetic products containing ingredients tested on animal models was forbidden in 2009. In consequence of these boundaries, the European Centre for the Validation of Alternative Methods (ECVAM) proposes a list of validated cell-based in vitro models for predicting the safety and toxicity of cosmetic ingredients. These models have been demonstrated as valuable and effective tools to overcome the limitations of animal in vivo studies. Although the use of in vitro cell-based models for the evaluation of absorption and permeability of cosmetic ingredients is widespread, a detailed study on the properties of these platforms and the in vitro-in vivo correlation compared with human data are required. Moreover, additional efforts must be taken to develop in vitro models to predict carcinogenicity, repeat dose toxicity and reproductive toxicity, for which no alternative in vitro methods are currently available. This review paper summarizes and characterizes the most relevant in vitro models validated by ECVAM employed to predict the safety and toxicology of cosmetic ingredients.

[1]  Valérie Zuang,et al.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 , 2011, Archives of Toxicology.

[2]  Sieto Bosgra,et al.  Interpreting in vitro developmental toxicity test battery results: The consideration of toxicokinetics. , 2015, Reproductive toxicology.

[3]  R L Kodell,et al.  A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients. , 2011, Regulatory toxicology and pharmacology : RTP.

[4]  J. G. Hengstler,et al.  Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH) , 2008, Archives of Toxicology.

[5]  A Worth,et al.  Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients. , 2014, Toxicology letters.

[6]  I Kimber,et al.  Models for contact sensitization‐novel approaches and future developments , 1986, British Journal of Dermatology.

[7]  Nicola J Hewitt,et al.  A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis. , 2010, Regulatory toxicology and pharmacology : RTP.

[8]  Hayato Nishida,et al.  Non-animal photosafety assessment approaches for cosmetics based on the photochemical and photobiochemical properties. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  Annamaria Colacci,et al.  BALB/c 3T3 cell transformation assay for the prediction of carcinogenic potential of chemicals and environmental mixtures. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  Harvey J Clewell,et al.  PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop. , 2014, Regulatory toxicology and pharmacology : RTP.

[11]  Nathalie Alépée,et al.  In vitro assessment of eye irritancy using the Reconstructed Human Corneal Epithelial SkinEthic HCE model: application to 435 substances from consumer products industry. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  P. Vanparys,et al.  Prevalidation of a new in vitro reconstituted human cornea model to assess the eye irritating potential of chemicals. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[13]  M. Pemberton,et al.  An in vitro skin corrosivity test--modifications and validation. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  Bruno Sarmento,et al.  Cell-based in vitro models for predicting drug permeability , 2012, Expert opinion on drug metabolism & toxicology.

[15]  Francisca Rodrigues,et al.  Cell-based in vitro models for dermal permeability studies , 2016 .

[16]  Marilyn J Aardema,et al.  Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: application of the EpiDerm human reconstructed epidermis model. , 2009, Toxicology letters.

[17]  G Frank Gerberick,et al.  Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  J H Fentem,et al.  Non-animal testing strategies for assessment of the skin corrosion and skin irritation potential of ingredients and finished products. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  M. Pemberton,et al.  An in vitro model for identifying skin-corrosive chemicals. I. Initial validation. , 1988, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  D A Basketter,et al.  The skin corrosivity test in vitro. Results of an inter-laboratory trial. , 1992, Toxicology in vitro : an international journal published in association with BIBRA.

[21]  Andreas Natsch,et al.  Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  Steven J Canipa,et al.  Predicting skin sensitisation using a decision tree integrated testing strategy with an in silico model and in chemico/in vitro assays. , 2016, Regulatory toxicology and pharmacology : RTP.

[23]  M. Mommaas,et al.  Lipid and ultrastructural characterization of reconstructed skin models. , 2000, International journal of pharmaceutics.

[24]  Zuang Valerie,et al.  EURL ECVAM progress report on the development, validation and regulatory acceptance of alternative methods (2010-2013)Prepared in the framework of Directive 76/768/EEC and Regulation (EC) No 1223/2009 on cosmetic products , 2013 .

[25]  Mitchell Klausner,et al.  Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay. , 2009, Mutation research.

[26]  Annette Petersen,et al.  Physicologically Based Toxicokinetic Models of Tebuconazole and Application in Human Risk Assessment. , 2016, Chemical research in toxicology.

[27]  M Liebsch,et al.  Validation study of alternatives to the Draize eye irritation test in Germany: Cytotoxicity testing and HET-CAM test with 136 industrial chemicals. , 1993, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  A Worth,et al.  In vitro-to-in vivo correlation of the skin penetration, liver clearance and hepatotoxicity of caffeine. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[29]  Thomas Peyret,et al.  Physiologically Based Toxicokinetic (PBTK) Modeling in Ecotoxicology , 2009 .

[30]  Nicola J Hewitt,et al.  International prevalidation studies of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility. , 2010, Mutation research.

[31]  Casati Silvia,et al.  EURL ECVAM Recommendation on the human Cell Line Activation Test (h-CLAT) for skin sensitisation testing , 2015 .

[32]  Raffaella Corvi,et al.  Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics. , 2012, Mutation research.

[33]  Hermann-Georg Holzhütter,et al.  In Vitro Phototoxicity Testing: Development and Validation of a New Concentration Response Analysis Software and Biostatistical Analyses Related to the Use of Various Prediction Models , 2002, Alternatives to laboratory animals : ATLA.

[34]  Zuang Valerie,et al.  The EURL ECVAM - Cosmetics Europe prospective validation study of Reconstructed human Cornea-like Epithelium (RhCE)-based test methods for identifying chemicals not requiring classification and labelling for serious eye damage/eye irritation: Validation Study Report , 2014 .

[35]  T. Knudsen,et al.  A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.

[36]  D Jirová,et al.  Phototoxicity of bituminous tars-correspondence between results of 3T3 NRU PT, 3D skin model and experimental human data. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[37]  G Frank Gerberick,et al.  Development of a peptide reactivity assay for screening contact allergens. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  Hans Raabe,et al.  Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50>2000 mg/kg): results of an ECVAM validation study. , 2013, Regulatory toxicology and pharmacology : RTP.

[39]  J Scheel,et al.  Report from the EPAA workshop: in vitro ADME in safety testing used by EPAA industry sectors. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[40]  Ayako Sakai,et al.  BALB/c 3T3 cell transformation assays for the assessment of chemical carcinogenicity , 2008 .

[41]  Raffaella Corvi,et al.  Comet assay in reconstructed 3D human epidermal skin models—investigation of intra- and inter-laboratory reproducibility with coded chemicals , 2013, Mutagenesis.